Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
165studies shown
Showing 25-36 of 165
Drug study icon
RecruitingNCT06926829

A Long-term study of EB-1020 in adults with ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Tokyo
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Drug study icon
RecruitingNCT07087327

A Long-term study of EB-1020 in Pediatric people with ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Sapporo
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 6 Years to 17 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Behavioral study icon
RecruitingNCT06743425

A Study of a Remote ADHD Monitoring Program

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Jackson
Why is this study shown?

This study is directly about ADHD.

ADHDBehavioralFrom 5 Years to 11 Years
Countries
United States
Sponsor
IDeA States Pediatric Clinical Trials Network
Condition
ADHD
Drug study icon
RecruitingISRCTN60701389

A study to test whether a new website, Sleep Buddy, developed by doctors and psychologists, can help parents and carers of children aged 6-12 years with a diagnosis of ADHD who are experiencing sleep problems to improve their child’s sleep

The registry lists this study as recruiting. Study locations are listed in the United Kingdom.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 6 Years to 12 Years
Countries
United Kingdom
Sponsor
University Hospital Southampton NHS Foundation Trust
Condition
ADHD
Drug study icon
RecruitingNCT07086313

EB-1020 for ADHD

The registry lists this study as recruiting. Study locations are listed in Japan.

In Sapporo
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 6 Years to 17 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Device study icon
RecruitingNCT06325813

ADHD PreSMA Response Inhibition Therapy

This summary needs review. Please check the official study record and contact the research team for details.

In Cincinnati
Why is this study shown?

This study is directly about ADHD.

ADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 12 Years to 17 Years
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Condition
ADHD
Drug study icon
RecruitingNCT06577779

An Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening

The registry lists this study as recruiting. Study locations are listed in the United States.

In New York
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
ADHD
Device study icon
RecruitingNCT07203092

Effects of Transcranial Photobiomodulation in ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Austin
Why is this study shown?

This study is directly about ADHD.

ADHDDeviceFrom 18 Years to 44 Years
Countries
United States
Sponsor
Francisco Gonzalez-Lima, PhD
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.